| USGOV-DEPARTMENT-OF-JUSTICE |
USGOV-DEPARTMENT-OF-JUSTICE |
95%
|
USAspending awards from Department of Justice: $87,006 across 2 awards. 15B50525F00000191 OPSUMIT 10MG-QTY 4 @ $6,270.03 ADEMPAS 1MG, QTY 1 @ $12,153.05 REMODULIN 5MG/ML INJ 20ML VIAL, QTY 1 @ $6,206… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
95%
|
USAspending awards from Department of Veterans Affairs: $651,394 across 8 awards. 36C26124N0646 TYVASO; 36C26024F0248 TYVASO; 36C26026F0064 TYVASO KITS & CARTRIDGES | Qwen corrected direction: Explic… |
| DISTRIBUTOR-1 |
DISTRIBUTOR-1 |
90%
|
We recorded revenue from two distributors in the United States that exceeded ten percent of total revenues. |
| DISTRIBUTOR-2 |
DISTRIBUTOR-2 |
90%
|
We recorded revenue from two distributors in the United States that exceeded ten percent of total revenues. |
| CVS |
CVS Health Corporation |
72%
|
usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine… |
| CVS |
CVS Health Corporation |
72%
|
Reciprocal relationship from CVS graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from CVS graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from CVS grap… |
| CAPITAL-RESOURCES |
CAPITAL-RESOURCES |
62%
|
lement of the 2025 Uncollared ASR occurred in November 2025, and we received an additional 3,882 shares of our common stock upon settlement. The final settlement of the 2025 Collared ASR occurred in … |
| CRS |
Carpenter Technology Corporation |
62%
|
Reciprocal relationship from CRS graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from CRS graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from CRS grap… |
| DELAWARE-GENERAL-CORPORATION |
DELAWARE-GENERAL-CORPORATION |
62%
|
companies. If we are not able to successfully identify, finance, consummate, and/or integrate acquisitions, our business operations and financial position could be adversely affected. We seek to expa… |
| LIQT |
LiqTech International, Inc. |
62%
|
Reciprocal relationship from LIQT graph: Reciprocal relationship from UTHR graph: Reciprocal relationship from LIQT graph: Reciprocal relationship from UTHR graph: usion devices, including the Remuni… |
| LIQUIDIA-PAH-LLC |
LIQUIDIA-PAH-LLC |
62%
|
usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine… |
| LIQUIDIA-TECHNOLOGIES-INC |
LIQUIDIA-TECHNOLOGIES-INC |
62%
|
usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine… |
| PHILLIPS-MEDISIZE-CORP |
PHILLIPS-MEDISIZE-CORP |
62%
|
manufacturers that supply them. Lilly manufactures and supplies Adcirca for us. We use Lilly’s pharmaceutical wholesaler network to distribute Adcirca. If Lilly is unable to manufacture or supply Adc… |
| RAREGEN-LLC |
RAREGEN-LLC |
62%
|
usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine… |
| SMITHS-MEDICAL-ASD-INC |
SMITHS-MEDICAL-ASD-INC |
62%
|
usion devices, including the Remunity ® and RemunityPRO ® Pumps. 18 United Therapeutics, a public benefit corporation Table of Contents Part I. Financial Information Geographic revenues are determine… |